| 产品详情 |
| Edit |   |
|---|
| Product Name | Recombinant Human Matriptase/ST14 Catalytic Domain, CF |
|---|
| Description | Purity >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining. MW (observed): 27 kDa (major) and minor auto-activation fragments, reducing conditions. MW (theoretical): 26 kDa. The Recombinant Human Matriptase/ST14 Catalytic Domain from R&D Systems is derived from E. coli. The Recombinant Human Matriptase/ST14 Catalytic Domain has been validated for the following applications: Enzyme Activity. |
|---|
| Size | 10 ug |
|---|
| Concentration | n/a |
|---|
| Applications | Enzyme Activity |
|---|
| Other Names | EC 3.4.21, Epithin, HAI, Matriptase, Membrane-type serine protease 1, MTSP1, MT-SP1EC 3.4.21.109, prostamin, PRSS14, Serine protease 14, Serine protease TADG-15, SNC19, SNC19MTSP1, ST14, suppression of tumorigenicity 14 (colon carcinoma), suppression of tumorigenicity 14 (colon carcinoma, matriptase, epithin), suppressor of tumorigenicity 14 protein, TADG15, TADG-15, TMPRSS14, tumor associated differentially expressed gene 15 protein, Tumor-associated differentially-expressed gene 15 protein |
|---|
| Gene, Accession, CAS # | Gene ID: 6768, Accession: NP_068813 |
|---|
| Catalog # | 3946-SEB-010 |
|---|
| Price | |
|---|
| Order / More Info | Recombinant Human Matriptase/ST14 Catalytic Domain, CF from R&D SYSTEMS, INC. |
|---|
| Product Specific References | PubMed: 18310226, 20601429, 20657595, 22383955, 23548907, 24617769, 27459298, 28358853, 30409910, 30606244 |
|---|
| 产品资料 |
|
|